BLS Nasal Naloxone (Narcan)

Thank you for your interest in the Basic Life Support (BLS) Naloxone Administration program. The goal of this program is to provide faster appropriate care to Opioid Overdose patients in our region.

At the October, 2013 meeting of the New York State Emergency Medical Advisory Committee (SEMAC), the administration of naloxone (Narcan®) using a mucosal atomizer device (MAD) for patients experiencing opioid overdoses was approved for use by certified Basic Life Support EMS providers in Basic Life Support (BLS) EMS agencies. The Commissioner of Health has approved the administration of intranasal naloxone as a part of the scope of practice for certified Basic Life Support EMS providers in New York State.

Before beginning this program, agencies must:
  1. Create polices and procedures as described in Policy Statement 13-10.
  2. Provide training as described in Policy Statement 13-10, and FAQ #16. Please note the WREMAC has created a PowerPoint that may be used instead of the video.
  3. Have a plan in place to comply with the QA/QI requirements as described in Policy Statement 13-10, and FAQ #1.
  4. Turn in a Letter of intent (including medial director signature) to their program agency.
The letter of intent is the only form that must be turned in. Agencies may begin as soon as they confirm their paperwork has been received by the program agency (They do not need to wait for the next WREMAC approval).

For information on First Responder Nasal Naloxone in the Big Lakes Region provided by Lake Plains, please visit our Opioid Overdose Prevention Page.



Send your forms to:
Attn: BLS Nasal Naloxone
Lake Plains Community Care Network, Inc.
575 East Main Street
Batavia, NY 14020